Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Merck buys Idenix

June 10, 2014 Manufacturing and Production, Sales and Marketing HCV, IDX21437, IDX21459, Merck, hep C, idenix

Merck is to improve its pipeline of hepatitis C virus (HCV) treatments by splashing out $3.85 billion on biopharma firm …
News

Dendreon chief resigns from struggling firm

June 10, 2014 Medical Communications, Sales and Marketing Cancer, Dendreon, John Johnson, Provenge, Vaccine, Watson, prostate

Chief executive of Dendreon John Johnson is to step down in the summer amid falling sales of the company’s key …
News

Sovaldi hurdles first drug pricing barrier

June 10, 2014 Sales and Marketing Gilead, SMC, Scotland, hep C, sofosbuvir, sovaldi

Scotland’s NHS will pay for Gilead’s new hepatitis C pill Sovaldi despite rising concern over its high cost. The Scottish …
News

Langland hires business unit director

June 10, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Langland, Michael Le Brocq

Healthcare advertising agency Langland has appointed Michael Le Brocq as business unit director for its Ethical division.  Also joining the …
Appointment

Lilly app targets depression

June 10, 2014 Medical Communications, Sales and Marketing Android, depression, iphone, lilly, talking progress

Eli Lilly has launched a free mobile app for Android and iPhone handsets which aims to support patients who suffer …
News

Child flu pilot ‘encouraging’

June 9, 2014 Research and Development, Sales and Marketing UK, Vaccine, chid, children, flu, government, phd

Figures from the child flu vaccine pilot launched last year by Public Health England (PHE) are encouraging, the government says. …
News

Pharma, digital and patients: a healthy concoction?

June 9, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing adams, digital, epatient, pharma

A young woman sits stunned in an oncologist’s office, unsure of where to look or how to react to the …
Feature

IDEA Pharma appoints account manager

June 9, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing idea, ritacco

IDEA Pharma has hired Rick Ritacco as an account manager to join its New York practice working with the company’s …
Appointment

Penn Pharma starts operations

June 9, 2014 Manufacturing and Production, Sales and Marketing API, Penn Pharma, Wales, manufacturing, south

Penn Pharma has opened its expanded facility in South Wales, after a £3 million investment which will allow it to …
News

Pradaxa gets DVT indication

June 6, 2014 Sales and Marketing Boehringer, DVT, Pradaxa, blood, dabigatran etexilate, thinner

Pradaxa has been given approval in Europe to treat deep vein thrombosis (DVT) and pulmonary embolism (PE) just a week …
News

Bayer announces more changes at the top

June 6, 2014 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Dieter Weinand, Otsuka, dekkers, healthcare

US-based president at Japanese drugmaker Otsuka, Dieter Weinand, is to join Bayer Healthcare Pharmaceuticals as the new head of its …
News

Andy Burnham: NHS needs a ‘reset’

June 6, 2014 Medical Communications, Sales and Marketing Hunt, NHS, burnham, confederation, reset

The NHS must be ‘reset’ in order to make it into a 21st century health service, according to shadow health …
News

Skills crisis looming in pharma, says report

June 6, 2014 Medical Communications, Research and Development, Sales and Marketing Jobs, career, life sciences, medcity, pharma, skills

 More than half of life sciences employers expect to face a serious shortage of experienced job applicants in the coming …
News

RSA appoints US business lead



June 6, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mccabe, molloy, rsa

Life sciences recruitment firm RSA has confirmed the appointment of Elizabeth McCabe as its head of RSA North America.  With …
Appointment

EMA accepts Boehringer IPF drug

June 6, 2014 Sales and Marketing Boehringer, EMA, IPF, inpulsis, lung, nintedanib

Boehringer Ingelheim has moved a step closer to getting its investigational treatment nintedanib approved in Europe for a potentially fatal …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026